JP2009511593A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009511593A5 JP2009511593A5 JP2008535686A JP2008535686A JP2009511593A5 JP 2009511593 A5 JP2009511593 A5 JP 2009511593A5 JP 2008535686 A JP2008535686 A JP 2008535686A JP 2008535686 A JP2008535686 A JP 2008535686A JP 2009511593 A5 JP2009511593 A5 JP 2009511593A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- substituted
- optionally substituted
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72661605P | 2005-10-13 | 2005-10-13 | |
| PCT/US2006/039975 WO2007047401A2 (en) | 2005-10-13 | 2006-10-11 | A1 adenosine receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009511593A JP2009511593A (ja) | 2009-03-19 |
| JP2009511593A5 true JP2009511593A5 (cg-RX-API-DMAC10.html) | 2009-11-12 |
Family
ID=37865975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008535686A Pending JP2009511593A (ja) | 2005-10-13 | 2006-10-11 | Ａ１アデノシンレセプターアゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7488720B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1943251B8 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2009511593A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE497960T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2625783A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE602006020057D1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2358351T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2007047401A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488720B2 (en) * | 2005-10-13 | 2009-02-10 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
| CN101712709A (zh) * | 2008-10-06 | 2010-05-26 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷及其调血脂的用途 |
| CN120647702A (zh) | 2017-05-19 | 2025-09-16 | 全技术公司 | 药剂、组合物及其相关方法 |
| EP4541803A4 (en) * | 2022-06-17 | 2025-10-01 | Shanghai Senhui Medicine Co Ltd | CYCLOPENTYLADENOSINE DERIVATIVE AND ITS PHARMACEUTICAL USE |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| ES2264826T3 (es) * | 1998-10-16 | 2007-01-16 | Pfizer Inc. | Derivados de adenina. |
| US20030013675A1 (en) * | 2001-05-25 | 2003-01-16 | Boehringer Ingelheim Pharma Kg | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |
| US20030078232A1 (en) | 2001-08-08 | 2003-04-24 | Elfatih Elzein | Adenosine receptor A3 agonists |
| WO2004069185A2 (en) * | 2003-02-03 | 2004-08-19 | Cv Therapeutics Inc. | Partial and full agonists of a1 adenosine receptors |
| US7488720B2 (en) * | 2005-10-13 | 2009-02-10 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
-
2006
- 2006-10-11 US US11/546,658 patent/US7488720B2/en not_active Expired - Fee Related
- 2006-10-11 WO PCT/US2006/039975 patent/WO2007047401A2/en not_active Ceased
- 2006-10-11 ES ES06825861T patent/ES2358351T3/es active Active
- 2006-10-11 DE DE602006020057T patent/DE602006020057D1/de active Active
- 2006-10-11 JP JP2008535686A patent/JP2009511593A/ja active Pending
- 2006-10-11 EP EP06825861A patent/EP1943251B8/en active Active
- 2006-10-11 AT AT06825861T patent/ATE497960T1/de active
- 2006-10-11 CA CA002625783A patent/CA2625783A1/en not_active Abandoned
-
2009
- 2009-02-03 US US12/365,072 patent/US20090137520A1/en not_active Abandoned